Market revenue in 2023 | USD 100.9 million |
Market revenue in 2030 | USD 169.4 million |
Growth rate | 7.7% (CAGR from 2023 to 2030) |
Largest segment | X-ray/computed tomography |
Fastest growing segment | Magnetic Resonance Imaging |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Ultrasound, Magnetic Resonance Imaging, X-ray/Computed Tomography |
Key market players worldwide | Bayer AG, GE Aerospace, Guerbet, Bracco, Lantheus Holdings Inc, Imax Corp, Nano Therapeutics, Trivitron Healthcare |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to contrast media market will help companies and investors design strategic landscapes.
X-ray/computed tomography was the largest segment with a revenue share of 70.76% in 2023. Horizon Databook has segmented the Norway contrast media market based on ultrasound, magnetic resonance imaging, x-ray/computed tomography covering the revenue growth of each sub-segment from 2018 to 2030.
Healthcare expenditure in Norway is gradually increasing, and the government & players are focusing on enhancing the country’s medical facilities. Regional Health Authorities, along with the Ministry of Health and Care Services, are running public hospitals in the country.
The government provides coverage for medical care to its citizens. Moreover, private insurance is effective and affordable. Moreover, the presence of major market players, such as GE Healthcare, undertaking various strategic initiatives to hold a strong share in the market, is expected to contribute to the market growth.
For instance, in November 2022, GE Healthcare's Pharmaceutical Diagnostics division unveiled USD 80 million investment plan aimed at expanding its manufacturing capacity by 30 percent at its Active Pharmaceutical Ingredients (API) facility located in Lindesnes, Norway.
Horizon Databook provides a detailed overview of country-level data and insights on the Norway contrast media market , including forecasts for subscribers. This country databook contains high-level insights into Norway contrast media market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account